glp-1 receptor agonists in idiopathic intracranial hypertension may improve outcomes The effect of glucagon-like peptide-1
Description
doi: 10.1001/jamainternmed.2025.1794 54 MehrtashFDushayJMansonJE
While initial animal studies demonstrated a potential biological mechanism for increased risk of PDAC, this has not been observed in humans to date
Studies show just correlation, so far Experts say the latest data is still far from being able to conclude that GLP-1s are effective treatments for cancer
Subgroup analyses showed no significant interactions for the six-composite end point across 12 prespecified clinical and demographic subgroups except for a marginal interaction for BMI subgroups
